13 | Hod5.79 R@30dma7.ish Yet I feel this could be | znewcar1 | 01/29/2024 1:35:07 PM |
12 | Knocking @5.71 afts5.6ish the BO6 then R@$2 then | znewcar1 | 01/29/2024 12:27:59 PM |
11 | PDSB Hod5.74 ML3.93 weekly chart thin in +> the | znewcar1 | 01/29/2024 11:40:36 AM |
10 | $PDSB 23% v2,7M c11.40 f28,5M H11.48 ML7.95 | znewcar1 | 12/28/2022 4:39:29 PM |
9 | PDSB 26% v30,8M c7.27 f22,2M | znewcar1 | 05/20/2021 5:44:18 PM |
8 | PDSB 53% v8,5M c6.81 f22,2M | znewcar1 | 02/09/2021 4:41:33 PM |
7 | PDSB .18% v2,3M c2.47 f22,2M | znewcar1 | 11/04/2020 7:11:15 PM |
6 | PDSB - Save the date - Oct 6th - Virtual roadshow | schoolofrock | 09/30/2020 1:57:12 PM |
5 | PDSB 39% v5,1M c4.19 f15,3M H4.37 gap with a | znewcar1 | 07/20/2020 6:15:25 PM |
4 | PDSB 20% v3,0M c3.01 f15,3M H3.36 | znewcar1 | 07/17/2020 11:53:22 PM |
3 | PDSB 33% v3,4M c2.72 f15,3M H2.88 EOD | znewcar1 | 07/15/2020 6:36:11 PM |
2 | PDSB 60% v36,7M c2.60 f15,3M gap up rip through | znewcar1 | 06/29/2020 8:18:47 PM |
1 | PDSB 31% v1,M c3.94 f5M IPO | znewcar1 | 10/03/2019 4:09:47 PM |
Recent Articles
- Investa Expands Horizons with New Crowdcube Fundraising Venture
- IO Biotech Unveils Phase 3 Findings on Cylembio and KEYTRUDA
- AlphaMedix Phase 2 Study Highlights Transformative Potential
- AlphaMedix Phase 2 Study Reveals Hope for GEP-NET Treatment
- BT-001 Shows Promise in Advanced Solid Tumors Alongside Therapy
- Innovative Solutions in Automotive Cybersecurity via FD-SOI
- Key Insights on Debtor Distribution Data for Investors
- Nykredit Realkredit A/S Publishes Important Debtor Data
- Recent Progress in US-South Korea Tariff Negotiations Explained
- Understanding Nvidia's Energy Challenge Amid AI Advancements
- Navigating the Class Action for MoonLake Immunotherapeutics
- Investors Encouraged to Join Lawsuit Against Quanex Building Products
- Liquid Wind Marks Major Milestone for eFuel Production Facility
- Chung Kisun Elevated to Chairman of HD Hyundai Leadership
- Nordic Fusion Energy Development: Future Prospects and Locations
- EXEED's Texxeract Technology Unveiled with New Model Designs
- Effective Immunotherapy Approaches for Aggressive Skin Cancer
- VAALCO Energy Announces Upcoming Earnings Conference Details
- MILESEEY Golf’s Innovative GenePro G1 Rangefinder Shines Bright
- Chery's Ride Green Life: A Step Towards Global Sustainability
- Hengrui Pharma Showcases Groundbreaking Oncology Research at ESMO
- Foresight Group's Strategic Share Buyback Initiatives Explained
- Infortar Launches Strategic Buy-Back of Shares to Boost Value
- Mothercare plc Focuses on Growth with Pension Contributions Deferral
- Exploring the Recent Buy-Back Activities of AB Artea Bankas
- Jyske Bank's Share Repurchase Results in October 2025
- Chengdu CATANIA's Tower 2: A New Era for Luxury Living
- Highlighting Innovation: The 2025 International College Contest Finale
- Accord Plasma B.V. Strengthens Global Plasma Solutions Through Acquisition
- Exciting Data Arrival: Pharming Group's Latest Breakthroughs
- Innovations in Power Module Packaging Driving Industry Growth
- VAALCO Energy Schedules Q3 Earnings Announcement and Call
- STMicroelectronics Launches Next-Gen Image Sensors for Vision
- Aberforth Partners LLP Reports Major Holdings in Kenmare
- Insightful Share Buyback Announcement from NB Private Equity
- Orkela Secures EUR 40 Million Credit Deal with SEB Bank
- Chery’s Innovative Approach to Mobility Attracts Global Users
- Bank of America Adjusts Shareholding in TCM Group A/S
- Zions Bancorp Prepares for Q3 Earnings: Analyst Insights Revealed
- Kelun-Biotech Unveils Promising Results in Cancer Treatment
- Exploring Atlanta's Thriving Scuba Scene and Training Hub
- Sampo plc Announces Major Share Buybacks with Financial Insights
- Paratus Energy Services Rejoices Over Recent Financial Milestone
- Significant Payment Boost for Paratus Energy Services Ltd.
- Nextensa and Promobe Secure Long-Term Lease for New Offices
- China's Rare Earth Controls: An Uncertain Gamble Ahead
- Transform Your Finances: The Military Money Manual Unveiled
- FORVIA Reports Steady Q3 2025 Sales of €6.1 Billion
- High-Dose Influenza Vaccine Promises Greater Protection for Seniors
- Corbion Share Buyback Program Update: Significant Progress Made